Lüker Jakob, Sultan Arian, Plenge Tobias, Lee Samuel, van den Bruck Jan-Hendrik, Steven Daniel
Department of Electrophysiology, University Hospital Cologne, Kerpener Straße 62, 50823, Cologne, Germany.
Herzschrittmacherther Elektrophysiol. 2018 Mar;29(1):127-132. doi: 10.1007/s00399-017-0538-7. Epub 2017 Nov 14.
Propofol is one of the most commonly used intravenous anaesthetic drugs for surgical procedures. The use of propofol for sedation is also common practice during endoscopic procedures, electrophysiology studies, and ablation procedures, as well as pacemaker and defibrillator implantation. It was found that propofol alters the electrophysiologic properties of the heart and its conduction system. The effects of propofol on pacing thresholds are unknown and could have implications for pacemaker (PM) and defibrillator (ICD) implantation procedures, as well as sedation and anaesthesia in PM and ICD patients in general.
We sought to investigate the effects of propofol sedation on atrial and right ventricular pacing thresholds in PM and ICD patients.
A total of 50 patients with PM, ICD, or cardiac resynchronization therapy (CRT) undergoing propofol sedation for electrophysiology (EP) investigation, transesophageal echocardiography (TEE), electrocardioversion (ECV), or bronchoscopy were included prospectively. Pacing thresholds, impedance, and sensing were assessed by device interrogation immediately prior to sedation and after the desired sedation depth was achieved by the administration of propofol.
Mean atrial (0.68 V vs 0.77 V, p = 0.136) and mean right ventricular thresholds (0.90 V vs 0.93 V, p = 0.274) remained unchanged. Impedances and sensing remained unaffected in all patients.
Propofol sedation did not affect pacing thresholds of atrial and right ventricular leads in this cohort of PM and ICD patients.
丙泊酚是外科手术中最常用的静脉麻醉药物之一。在进行内镜检查、电生理研究、消融手术以及起搏器和除颤器植入手术时,使用丙泊酚进行镇静也很常见。研究发现,丙泊酚会改变心脏及其传导系统的电生理特性。丙泊酚对起搏阈值的影响尚不清楚,这可能对起搏器(PM)和除颤器(ICD)植入手术以及一般PM和ICD患者的镇静和麻醉产生影响。
我们试图研究丙泊酚镇静对PM和ICD患者心房和右心室起搏阈值的影响。
前瞻性纳入50例因电生理(EP)检查、经食管超声心动图(TEE)、心脏复律(ECV)或支气管镜检查而接受丙泊酚镇静的PM、ICD或心脏再同步治疗(CRT)患者。在镇静前及通过给予丙泊酚达到所需镇静深度后,通过设备询问评估起搏阈值、阻抗和感知功能。
平均心房阈值(0.68V对0.77V,p = 0.136)和平均右心室阈值(0.90V对0.93V,p = 0.274)保持不变。所有患者的阻抗和感知功能均未受影响。
在该组PM和ICD患者中,丙泊酚镇静不影响心房和右心室导联的起搏阈值。